Trial Profile
Phase 1 Study of MKC-1 in Patients With Advanced or Metastatic Solid Malignancies.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 01 Oct 2014
Price :
$35
*
At a glance
- Drugs MKC 1 (Primary)
- Indications Solid tumours
- Focus Adverse reactions
- Sponsors CASI Pharmaceuticals; EntreMed
- 17 Dec 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 17 Dec 2009 Actual end date (Nov 2009) added as reported by ClinicalTrials.gov.
- 15 Jul 2009 Actual initiation date changed from Apr 2008 to Mar 2008 as reported by ClinicalTrials.gov.